Center Laboratories, Inc. (TPEX:4123)
37.10
+0.90 (2.49%)
May 13, 2025, 1:30 PM CST
Center Laboratories Revenue
Center Laboratories had revenue of 378.86M TWD in the quarter ending March 31, 2025, with 4.25% growth. This brings the company's revenue in the last twelve months to 1.63B, up 14.83% year-over-year. In the year 2024, Center Laboratories had annual revenue of 1.62B with 16.06% growth.
Revenue (ttm)
1.63B
Revenue Growth
+14.83%
P/S Ratio
16.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
26.73B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.62B | 223.86M | 16.06% |
Dec 31, 2023 | 1.39B | 626.29M | 81.58% |
Dec 31, 2022 | 767.72M | 267.62M | 53.51% |
Dec 31, 2021 | 500.11M | -216.94M | -30.25% |
Dec 31, 2020 | 717.05M | -720.63M | -50.12% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |